Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{170952,
        author = {Gorantla Yogitha and Choda Prasanth Kumar},
        title = {Advances in Central Nervous System Drug Discovery: Current Trends and Future Directions},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {2230-2231},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=170952},
        abstract = {The discovery of drugs for treating diseases of the central nervous system (CNS) has been a challenging and highly rewarding area of pharmaceutical research due to its complexity like presence of Blood-Brain barriers and complex pathology of neurological disorders. Despite these hurdles, CNS drug discovery and development programs have been subjected to significant cutbacks and eliminations over the last decade. These innovations aim to overcome barriers like the blood-brain barrier and enhance the specificity and efficacy of treatments. This review discusses the latest programs in CNS discovery.},
        keywords = {CNS drug discovery, blood-brain barrier, neurological disorders, psychiatric disorders, gene therapy, nanomedicine, drug delivery.},
        month = {December},
        }